Paloma Bárcena Carrasco-rekin lankidetzan egindako argitalpenak (10)

2016

  1. Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: A new model to understand chemoresistance

    Blood, Vol. 127, Núm. 15, pp. 1896-1906

2015

  1. Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential

    Leukemia, Vol. 29, Núm. 5, pp. 1186-1194

  2. The cellular origin and malignant transformation of Waldenström macroglobulinemia

    Blood, Vol. 125, Núm. 15, pp. 2370-2380

2014

  1. Circulating clonotypic B cells in multiple myeloma and monoclonal gammopathy of undetermined significance

    Haematologica, Vol. 99, Núm. 1, pp. 155-162

  2. Immunophenotypic alterations of bone marrow myeloid cell compartments in multiple myeloma patients predict for myelodysplasia-associated cytogenetic alterations

    Leukemia

2013

  1. Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: A study in highly purified aberrant plasma cells

    Haematologica, Vol. 98, Núm. 2, pp. 279-287

  2. Detailed characterization of multiple myeloma circulating tumor cells shows unique phenotypic, cytogenetic, functional, and circadian distribution profile

    Blood, Vol. 122, Núm. 22, pp. 3591-3598

2006

  1. TCRγδ+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRγδ+ T-cells

    Leukemia, Vol. 20, Núm. 3, pp. 505-513

2004

  1. Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis

    American Journal of Pathology, Vol. 165, Núm. 4, pp. 1117-1127

2003

  1. TCRαβ+/CD4+ large granular lymphocytosis: A new clonal T-cell lymphoproliferative disorder

    American Journal of Pathology, Vol. 163, Núm. 2, pp. 763-771